Subscribe to RSS
DOI: 10.1055/s-2004-815461
Chrysopentamine, an Antiplasmodial Anhydronium Base from Strychnos usambarensis Leaves
The Post-Doctoral Fellowship Program of the Korea Science Engineering Foundation (KOSEF) and the Belgian National Fund for Scientific Research (FNRS) are gratefully acknowledged for their support to Y.H. Choi and M. Frédérich, respectively. This research was in part supported by a grant from the ”Fond de la Recherche Scientifique Médicale” (FRSM, Belgium, grant No 3 453 201)Michel Frédérich
Laboratory of Pharmacognosy
Natural and Synthetic Drug Research Center
University of Liège
Avenue de l'hôpital 1, B36
4000 Liège
Belgium
Phone: +32-4-366-4338
Fax: +32-4-366-4332
Email: M.Frederich@ulg.ac.be
Publication History
Received: June 13, 2003
Accepted: October 18, 2003
Publication Date:
06 February 2004 (online)
Abstract
A new derivative of strychnopentamine was isolated from the leaves of Strychnos usambarensis. This compound, named chrysopentamine, was identified by detailed spectroscopic methods (UV, IR, HR-ESI-MS, 1D and 2D NMR). Chrysopentamine presented an original hydroxy substitution on C-14 and an aromatization of the ring D of strychnopentamine leading to anhydronium base properties and exhibited strong antiplasmodial properties (IC50 less than 1 μM).
Strychnos usambarensis Gilg (Loganiaceae) is a tree which has been used traditionally in the preparation of a curarizing arrow poison in Rwanda [1]. In addition to curarizing quaternary alkaloids, tertiary alkaloids showing antiplasmodial and cytotoxic activities were also found in the leaves and root bark [2], [3], [4], [5] and, recently, we have showed that isostrychnopentamine (2) induces apoptosis in colon cancer cells by an original p53-independent pathway [6]. In the course of the development of an effective procedure for the extraction of strychnopentamine (1) and isostrychnopentamine (2) from the leaves of S. usambarensis, we isolated a new anhydronium base showing potent antiplasmodial properties. This new compound was named chrysopentamine (3), based on the Greek word ”chrysos” for gold or orange-yellow and on the analogy with strychnopentamine (five nitrogen atoms) (Fig. [1]).
The UV spectrum of 3 suggested a highly conjugated β-carbolinium chromophore. A bathochromic shift was observed in alkaline solutions, suggesting an anhydronium base moiety or/and a phenolic group. Despite the presence of a quaternary nitrogen in the corynanium part of the alkaloid, 3 was easily extractable by organic solvents under alkaline conditions (pH 8 - 9), indicating the presence of the zwitterionic form of an anhydronium base, as in dihydroflavopereirine (Fig. [1]) [7]. The FT-IR spectrum showed NH and/or OH vibrations, vinyl vibrations, ortho-disubstituted and ortho-tetrasubstituted benzene vibrations, but no CO vibrations were detectable. Based on HR-ESI-MS, C35H38N5O2 was determined as the molecular formula, with an [M + H]+ at m/z = 560.3044. This was indicative of the presence of five nitrogen atoms, one more than what was expected for a bisindole alkaloid.
The NMR spectral data of 3 are listed in Table [1]. The broad band decoupled 13C-NMR spectrum of 3 showed 35 carbon signals which were sorted by HSQC, HMBC and APT as two CH3, nine CH2, ten CH and 14 quaternary carbons. In the aromatic region, the COSY, TOCSY and HSQC spectra showed seven aromatic protons (represented by one four-spin system, one two-spin system and a singlet at δ = 7.77) and three protons from a vinylic side chain. The 1H- and 13C-NMR spectra of 3 were essentially similar to the spectra of 1 and 2 [8]. The principal differences with the 1 and 2 spectra were, in the aliphatic part of the 1H spectrum of 3, the absence of H-3, H-14ab, H-15, H-20, H-21 and the deshielding of H-5, H-6, H-16 and H-17 and, in the aromatic part of the spectra, the appearance of a singlet at δ = 7.77. This signal was correlated in the HMBC spectrum to C-5, C-20, C-19, C-3, C-2, C-15 and C-14, in the ROESY spectrum to H-5 and H-18, in the COSY spectrum to H-5 and H-19 and then attributed to H-21 (Table [1]). The deshielded 1H and 13C shifts of CH-21 were consistent with those of strychnochrysine or afrocurarine, possessing a pyridinium ring D in their corynane moiety [9], [10]. The aromatization of ring D of strychnopentamine could explain the major other modifications compared to the spectra of 1 and 2. The HMBC spectrum allowed the assignment of the quaternary carbons of the pyridinium ring. The C-20 is correlated to H-21, H-18 and H-16b, while the C-15 is correlated to H-21 and H-16ab, C-3 is coupled to H-5 and H-21 and finally the C-14 is attributed to the quaternary signal at δ = 160.9, which is correlated to H-16b and weakly with H-16a and H-21 (Table [1]). This much deshielded value of C-14 could be explained by the presence of a hydroxy substituent at this position. The presence of a supplementary hydroxy substituent was expected from the HR-ESI-MS which has shown the presence of two oxygen atoms. This phenol at C-14 could also participate in the bathochromic shifts observed in the UV spectrum of 3 in alkaline conditions. The phenol at C-11 did not participate in the bathochromic shift, as it has been demonstrated that 1 and 2 possessed a cryptophenolic function and presented therefore no bathochromic shift [8]. Compound 3 exhibited a stable brown-greenish coloration after detection with Fast Blue B reagent (phenol reagent) on TLC plates, while 1 and 2 presented only a transient purple coloration (consequence of the cryptophenolic function), which suggested the presence of a supplementary phenolic function for 3. This phenolic function could not be placed on the two indole moieties, because H-9, H-10, H-9′, H-10′, H-11′ and H-12′ were clearly identified by comparison with 1 and 2. The only possibility left was then the C-14 pyridinium position. To confirm the presence of two hydroxy substitutions, 1H-NMR spectra of 1, 2 and 3 were recorded in CDCl3. The spectra of 1 and 2 showed two extra NH peaks and one extra phenol peak at δ = 11.80, while the spectrum of 3 exhibited two additional NH peaks and two additional phenol peaks at δ = 10.60 (OH-14) and δ = 11.44 (OH-11). An OH substitution on C-14 is not very frequent for a corynane type alkaloid, but a 14-hydroxyrauniticine has been previously described [11]. Finally, the linkage C-15/C-16/C-17 between the two portions of the molecule was confirmed by correlations in the HMBC spectrum (C-15/H-16b; C-14/H-16b; C-20/H-16b; C-17/H-16b; C-17/H-5Žab) and in the COSY spectrum. The identity of the pyrrolidine ring was confirmed by correlations in the TOCSY spectrum (H-2′′-H-3′′-H-4′′-H-5′′).
The stereochemistry of 3 has still to be considered. The H-17β (C-17S) configuration was attributed by comparison of the CD spectra of 3 with those of 1 and 2 [2] and usambarine [12]. All these alkaloids gave a positive Cotton effect near 280 nm, which is indicative of a C-17S configuration [13]. This stereochemistry is corroborated by the presence, in the ROESY spectrum of the same correlations for H-17 for 1, 2, and 3 (Table [1]). The H-2′′α (C-2′′R) was proposed after comparison of the ROESY correlations of 3 with those of 1 (H-2′′α) and 2 (H-2′′β). Compound 3 presented an H-2′′-H-11′ correlation as strychnopentamine (1), while isostrychnopentamine (2) exhibited an H-23-H-11′ correlation, but no H-2′′-H-11′ correlation. These differences in ROESY couplings were consistent with strychnopentamine (1) and isostrychnopentamine (2) by molecular modeling [8], [14].
The in vitro antiplasmodial activity of chrysopentamine (3) was determined against three Plasmodium falciparum cell lines in comparison to chloroquine, quinine, strychnopentamine (1) and isostrychnopentamine (2) (see Table [2]). Chrysopentamine presented an IC50 around 500 nM against all tested Plasmodium lines. Compound 3 possessed a comparable activity against all chloroquine-resistant and -sensitive lines of P. falciparum, which is indicative of the absence of cross-resistance with chloroquine. Compared with other indolic anhydronium bases or quaternary alkaloids, such as tetradehydrolongicaudatine Y or guianensine [5], compound 3 exhibits the strongest antiplasmodial activity of this class of compounds.
Chrysopentamine (3), which exhibits strong antiplasmodial properties, is a novel indolomonoterpenoid alkaloid, which has five nitrogen atoms, an unusual phenolic substitution on C-14, and a pyridinium ring which puts the alkaloid in the relatively small family of indolic anhydronium bases.

Fig. 1 Chemical structures of strychnopentamine (1), isostrychnopentamine (2), and chrysopentamine (3).
Position | 1Ha | COSY H/H correlations |
TOCSY H/H correlations |
ROESY H/H correlations |
13Cb | HMBCc C-H correlations |
2 | 126.69 (q) | 6, 21 | ||||
3 | 133.78 (q) | 5, 21 | ||||
5 | 4.67 (t, 7.4) | 21, 6 | 6 | 6, 21 | 57.14 (CH2) | 21, 6 |
6 | 3.28 (m) | 5 | 5 | 5, 9 | 24.03 (CH2) | 5 |
7 | 114.79 (q) | 5, 6, 9, 10 | ||||
8 | 120.28 (q) | 10, 9, 6 | ||||
9 | 7.39 (d, 8.6) | 10 | 10 | 6, 10 | 120.02 (CH) | - |
10 | 6.72 (d, 8.6) | 9 | 9 | 9 | 113.62 (CH) | - |
11 | 155.92 (q) | 2′′, 10, 9 | ||||
12 | 108.40 (q) | 2′′, 10, 9 | ||||
13 | 138.74 (q) | 2′′, 9, 10 | ||||
14 | 162.46 (q) | 16ab, 21 | ||||
15 | 139.47 (q) | 21, 16ab | ||||
16a 16b |
3.46 (m) 3.63 (m) |
16b, 17 16a, 17 |
16b, 17 16a, 17 |
16b, 17 16a, 17 |
32.04 (CH2) | - |
17 (3′) | 4.63 (m) | 16ab | 16ab | 22, 16a, 16b | 61.73 (CH) | 16b, 5′b, 22, 5′a |
18a 18b |
5.45 (d, 17.2) 5.66 (d, 10.9) |
18b, 19 18a, 19 |
18b, 19 18a, 19 |
18b 18a, 21, 19 |
120.17 (CH2) | - |
19 | 6.95 (dd, 11, 18) | 21, 18ab | 18ab | 19b, | 132.42 (CH) | 21, 18b |
20 | 135.38 (q) | 21, 18ab, 16b | ||||
21 | 7.77 (s) | 19, 5 | - | 5, 18b | 127.28 (CH) | 5 |
N4′ Me (22) | 2.95 (s) | - | - | 17, 5′ab | 41.39 (CH3) | 5′b |
2′ | 131.34 (q) | 6Ža | ||||
5′a 5′b |
3.32 (m) 3.74 (m) |
5′b, 6′ab 5′a, 6′ab |
5′b, 6′ab 5′a, 6′ab |
5′b, 6′, 22 5′a, 22 |
49.19 (CH2) | 22, 6Ž |
6′a 6′b |
2.95 3.02 (m) |
5′ab 5′ab |
5′ab 5′ab |
5′ab | 18.62 (CH2) | 5′a |
7′ | 107.66 (q) | 5′ab, 6′, 9′ | ||||
8′ | 127.41 (q) | 9′, 10′, 12′ | ||||
9′ | 7.44 (d, 7.9) | 10′, 11Ž | 10′, 11′, 12′ | 10′ | 119.06 (CH) | 11′, 10′, 12′ |
10′ | 7.02 (t, 7.3) | 9′, 11′, 12′ | 9′, 11′, 12′ | 11′, 9′ | 120.28 (CH) | 12′ |
11′ | 7.11 (t, 7.3) | 10′, 12′, 9′ | 9′, 10′, 12′ | 10′, 12′ | 123.07 (CH) | 9′, 12′, 10′ |
12′ | 7.30 (d, 8.1) | 11′, 10′ | 9′, 10′, 11′ | 11′ | 112.16 (CH) | 10′, 9′, 11′ |
13′ | 138.28 (q) | 9′, 11′ | ||||
N1′′ Me (23) | 2.46 (s) | - | - | 5′′ab, 2′′ | 40.73 (CH3) | 2′′, 5′′a |
2′′ | 4.10 (t, 8.8) | 3′′ab | 5′′ab, 4′′, 3′′ab | 3′′b, 5′′a, 23, 11′ | 66.67 (CH) | 5′′b, 23 |
3′′a 3′′b |
1.96 (m) 2.51 (m) |
3′′b, 2′′, 4′′ 3′′a, 2′′, 4′′ |
3′′b, 4′′, 5′′ab, 2′′ 3′′a, 4′′, 5′′ab, 2′′ |
3′′b 3′′a, 4′′ |
32.87 (CH2) | 2′′, 5′′b, |
4′′a 4′′b |
2.10 (m) 2.11 (m) |
5′′ab, 3′′ab | 3′′ab, 2′′, 5′′ab | 5′′ab, 3′′b | 24.03 (CH2) | 5′′b, 5′′a, 3′′b |
5′′a 5′′b |
2.61 (m) 3.49 (m) |
5′′b, 4′′ 5′′a, 4′′ |
5′′b, 4′′, 3′′ab, 2′′ 5′′a, 4′′, 3′′ab, 2′′ |
5′′b, 4′′, 23 5′′a, 4′′, 23 |
57.14 (CH2) | 23, 3′′b, |
a Chemical shifts (δ) in ppm from TMS. Multiplicities and coupling constants in Hz are in parentheses. | ||||||
b Carbon multiplicities in parentheses were deduced from APT spectrum. | ||||||
c Correlations from C to the indicated hydrogens. |
Compound | FCA 20/Ghana (chloroquine-sensitive line) |
FCB1-R/Colombia (moderately chloroquine-resistant line) |
W2/Indochina (Laos) (chloroquine-resistant line) |
||||||
IC50 nM ± SDa | IC90 nM | nb | IC50 nM ± SDa | IC90 nM | nb | IC50 nM ± SDa | IC90 nM | nb | |
Strychnopentamine (1) | 117 ± 33 | 443 | 4 | N.D.c | N.D.c | 145 ± 20 | 2 982 | 4 | |
Isostrychnopentamine (2) | 120 ± 42 | 450 | 2 | 104 ± 36 | 386 | 3 | 152 ± 9 | 628 | 2 |
Chrysopentamine (3) | 579 ± 376 | 1 918 | 2 | 550 ± 149 | 1 980 | 6 | 507 ± 227 | 1 774 | 2 |
quinine | 269 ± 6 | 1 910 | 3 | 200 ± 33 | 2 740 | 4 | 413 ± 11 | 1 720 | 3 |
chloroquine | 11 ± 5 | 71 | 6 | 32 ± 19 | 84 | 3 | 284 ± 17 | 1 750 | 5 |
a Values are expressed as mean ± standard deviation. All tests were realized in duplicate. | |||||||||
b n = number of experiments. | |||||||||
c N.D. = not determined. |
Materials and Methods
General experimental procedures: UV, IR, CD and NMR spectrometers and procedures have been described previously [15] (NMR spectra were measured with a Bruker Avance 500 MHz spectrometer). The HR-ESI-MS were recorded on a Q-TOF III micromass spectrometer (Waters-Micromass, Manchester, UK). All solvents and current chemicals used were of analytical grade (Merck chemicals, VWR international).
Plant material: The leaves of Strychnos usambarensis Gilg were collected by one of the authors (L.A.) in Akagera National Park, Rwanda and identified by Dr. A. J. M. Leeuwenberg. Voucher specimens of the plant were deposited in the herbarium of the National Botanical Garden of Belgium at Meise and in the herbarium of the Pharmaceutical Institute, at Liège (N° 1397).
Extraction and isolation: The leaves of S. usambarensis (767 g) were percolated with 20 L of EtOAc (pH 8) until complete extraction of alkaloids. The extract was dissolved in 1 % HOAc, washed with CH2Cl2 and then repeatedly extracted with CH2Cl2 at pH 8. The combined CH2Cl2 extracts were concentrated to give 6.55 g crude alkaloid extracts. Three g of extract were then fractionated by MPLC on 180 g of Merck LichroSpher 60 RP Select B (12 μm) with a gradient of acetonitrile in sodium heptanesulfonate (1 g in 420 mL, fitted to pH 2 with H3PO4) (0 to 800 mL: 10 % acetonitrile; 800 mL to 1.5 l: 15 % acetonitrile; 1.3 to 1.8 L: 20 % acetonitrile; 1.8 to 5 L: 25 % acetonitrile; 5 L to end: 30 % acetonitrile), to give 80 mg of strychnophylline (200 - 400 mL), 30 mg of strychnofoline (500 - 600 mL), 20 mg of chrysopentamine (3) (2900 - 3000 mL), 1 g of strychnopentamine (1) (3200 - 3400 mL), 300 mg of 11-hydroxyusambarine (3700 - 4400 mL) and 600 mg of isostrychnopentamine (2) (4600 - 4800 mL). The fractions were precipitated by Mayer’s reagent and each precipitate was dissolved in MeOH-Me2CO-H2O (6 : 2:1) and the alkaloids converted to the chloride by passage through an Amberlite® IRA-420 column (VWR international). The fractions were detected by TLC (EtOAc/2-PrOH/NH4OH, 90 : 8:2). Compound 1 was finally purified on a Sephadex® LH20 (Amersham bioscience, Roosendaal, The Netherlands) column with methanol as mobile phase.
Chrysopentamine (3): Orange amorphous powder; coloration yellow, orange and red in solution, respectively at pH 3, 9 and 12; UV (MeOH + CH3COOH 1 %): λmax (log ε) = 231 (3.37), 290 (2.92), 320 (2.67), 457 (3.12); UV (MeOH): λmax (log ε) = 231 (3.37), 290 (2.92), 325 (2.67), 469 (3.12); UV (MeOH + NH4OH 1 %): λmax (log ε) = 231 (3.37), 290 (2.92), 325 (2.67), 469 (3.12); UV (MeOH + KOH 0.1 M 1 %): λmax (log ε) = 231 (3.37), 292 (2.92), 360 (2.67), 510 (3.12); IR (KBr): νmax = 3391, 2925, 2852, 1724 (w), 1622, 1589, 1554, 1450, 1308, 1255, 1232, 1157, 1119, 1039, 922, 804, 743, 599 cm-1; CD (MeOH): (Δε) 218 (-6.25), 230 (+ 3.13), 244 (-0.52), 274 (+ 1.06), 293 (-0.25); 1H- (400 MHz) and 13C- (100 MHz) NMR data are given in Table [1]; ESI-MS: m/z = 560 [MH+] (90), 519 (10), 376 (100), 185 (10); HR-ESI-MS: m/z [MH+] = 560.3044 (calcd. for C35H38N5O2 : 560.3026).
Plasmodium falciparum cell lines and assays : Three Plasmodium falciparum cell lines were used in this study. These strains, the culture conditions and assay procedures were described previously [15], [16], [17], [18], [19]. Chloroquine diphosphate (Sigma C6628), and quinine base (Aldrich 14 590 - 4) were used as antimalarial references.
#Acknowledgements
The authors thank Professor J. De Graeve and Mr. J. C. van Heugen (University of Liège) for recording the mass spectra, Prof. P. Colson (Macromolecular Chemistry, University of Liège) for measuring the CD, Prof. J. Boniver (Anatomie et Cytologie Pathologique, Université de Liège) for liquid scintillation measurements.
#References
- 1 Angenot L, Denoel A, Goffart M. Activité curarisante d'un Strychnos africain: le Strychnos usambarensis Gilg du Rwanda. J Pharm Belg. 1970; 25 73-7
- 2 Angenot L, Coune C, Tits M. Nouveaux alcaloïdes des feuilles du Strychnos usambarensis . J Pharm Belg. 1978; 33 11-23
- 3 Angenot L. Nouveaux alcaloïdes des feuilles du Strychnos usambarensis . Planta Med. 1975; 27 24-30
- 4 Wright C W, Bray D H, O'Neill M J, Warhurst D C, Phillipson J D, Quetin-Leclercq J. et al . Antiamoebic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis . Planta Med. 1991; 57 337-40
Michel Frédérich
Laboratory of Pharmacognosy
Natural and Synthetic Drug Research Center
University of Liège
Avenue de l'hôpital 1, B36
4000 Liège
Belgium
Phone: +32-4-366-4338
Fax: +32-4-366-4332
Email: M.Frederich@ulg.ac.be
References
- 1 Angenot L, Denoel A, Goffart M. Activité curarisante d'un Strychnos africain: le Strychnos usambarensis Gilg du Rwanda. J Pharm Belg. 1970; 25 73-7
- 2 Angenot L, Coune C, Tits M. Nouveaux alcaloïdes des feuilles du Strychnos usambarensis . J Pharm Belg. 1978; 33 11-23
- 3 Angenot L. Nouveaux alcaloïdes des feuilles du Strychnos usambarensis . Planta Med. 1975; 27 24-30
- 4 Wright C W, Bray D H, O'Neill M J, Warhurst D C, Phillipson J D, Quetin-Leclercq J. et al . Antiamoebic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis . Planta Med. 1991; 57 337-40
Michel Frédérich
Laboratory of Pharmacognosy
Natural and Synthetic Drug Research Center
University of Liège
Avenue de l'hôpital 1, B36
4000 Liège
Belgium
Phone: +32-4-366-4338
Fax: +32-4-366-4332
Email: M.Frederich@ulg.ac.be

Fig. 1 Chemical structures of strychnopentamine (1), isostrychnopentamine (2), and chrysopentamine (3).